Title:
PHARMACEUTICAL FOR TREATING NOVEL CORONAVIRUS INFECTION
Document Type and Number:
WIPO Patent Application WO/2023/054732
Kind Code:
A2
Abstract:
The present invention provides a pharmaceutical composition containing a coronavirus 3CL protease inhibitor in order to treat a novel coronavirus (COVID-19) infection. Provided is a pharmaceutical composition for treating a novel coronavirus (COVID-19) infection, said pharmaceutical composition containing, as an effective ingredient, a composite that includes a compound represented by formula (I) and fumaric acid.
Inventors:
SHIMIZU RYOSUKE (JP)
MATSUO YUMIKO (JP)
FUKUHARA TAKAHIRO (JP)
FUKAO KEITA (JP)
KURODA TAKAYUKI (JP)
NOBORI HARUAKI (JP)
ISHIBASHI TORU (JP)
MATSUO YUMIKO (JP)
FUKUHARA TAKAHIRO (JP)
FUKAO KEITA (JP)
KURODA TAKAYUKI (JP)
NOBORI HARUAKI (JP)
ISHIBASHI TORU (JP)
Application Number:
PCT/JP2023/001243
Publication Date:
April 06, 2023
Filing Date:
January 18, 2023
Export Citation:
Assignee:
SHIONOGI & CO (JP)
International Classes:
A61K31/53; A61K9/10; A61K9/20; A61K31/194; A61K47/12; A61K47/26; A61P11/00; A61P31/12; A61P31/14; A61P43/00; C07D403/14
Attorney, Agent or Firm:
SUGITA Ken-ichi et al. (JP)
Download PDF: